How Early-stage VCs are Adjusting in a Bear Market
As part of a panel session, hosted by Stephen Hansen, at the Anglonordic Life Science conference on 5 May, Optimum’s clients explored the latest dynamics of syndicate building for early-stage VCs.
Tag Archive for: Inkef Capital
Precirix raises EUR 80m in Series B to advance its pipeline of precision radiopharmaceuticals
Precirix NV, a clinical-stage biotechnology company developing precision radiopharmaceuticals in oncology, today announces the closing of a EUR 80m Series B financing round led by new investors INKEF Capital, Jeito Capital and Forbion as co-leads. Read more
TargED raises €39 million in a series A investment round
TargED is extremely pleased and proud to have raised €39 million in a Series A investment round! Together with an international investor syndicate we’ll pursue our common goal: to bring Microlyse into clinical development! Read press release
VC Investor Panel: Building the Future Champions
Watch a replay of the live session here or read our top takeaways below…
Optimum European Healthcare Investor Survey
European investors continue actively investing in healthcare. The survey held in May 2020 includes responses from 24 of the most influential European VCs, investing approximately EUR 15.5 billion in aggregate in the Healthcare sector.
